Integrated DNA Technologies Celebrates Grand Opening of Flagship European Facility
News Sep 24, 2008
Integrated DNA Technologies (IDT) has celebrated the grand opening of its flagship European facility in Haasrode Research Park, Leuven, Belgium.
According to Company, the 2000 m2 research and production site enables IDT to serve customers throughout Europe, the Middle-East, and Africa with the same speed and quality that have made IDT the industry leader in the United States.
Dr. Joseph A. Walder, IDT’s founder and CEO, led the grand opening event. He emphasized that Europe is IDT’s most important market outside North America, and that IDT has invested in the heart of Europe as part of its long-range strategy to serve the research community globally.
“Although our origins are in the U.S., IDT is now just as much a European company as we are an American one,” Dr. Walder stressed.
“We want researchers in Europe to benefit from IDT’s twenty-year commitment to tireless innovation and peerless quality in oligo synthesis,” Dr. Walder continued, “and we want to learn from our European colleagues how IDT can best support their research as the science and application of synthetic biology advances.”
Joining IDT and its many guests was the Mayor of Leuven, Louis Tobback, who expressed his gratitude for IDT’s commitment to Europe and to Belgium. Thanking Dr. Walder in particular, he spoke on behalf of his city and region: “It is an honour that IDT has chosen Leuven for its primary European operation, and we are confident that IDT’s investment will benefit Belgium, IDT, and scientists throughout Europe.
Staphylococcus epidermidis is an ubiquitous colonizer of healthy human skin, but it is also a notorious source of serious nosocomial infections. Now, a new machine learning technique will help predict the risk of developing a serious, and possibly life-threatening S. epidermidis infection.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019